Evidence map›Paper›PMID 28394942›Full record

ArticlePLoS genetics2017

Evidence for the evolutionary steps leading to mecA-mediated β-lactam resistance in staphylococci.

Joana Rolo, Peder Worning, Jesper Boye Nielsen, Rita Sobral, Rory Bowden, Ons Bouchami, Peter Damborg, Luca Guardabassi, Vincent Perreten, Henrik Westh and 3 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 80 citations in OpenAlex.

  1. Article
  2. First Report of a Multidrug-ResistantVeterinary sciences · 2026
    Article
  3. Review
  4. Article
  5. Journal of bacteriology · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Genetic Characterization of Antibiotic-ResistantAntibiotics (Basel, Switzerland) · 2024
    Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Staphylococcal Cassette ChromosomeInfection and drug resistance · 2022
    Article
  17. Article
  18. Discovery of Pyrrolidine-2,3-diones as Novel Inhibitors ofAntibiotics (Basel, Switzerland) · 2021
    Article
  19. Review
  20. Unconventional Antibacterials and Adjuvants.Accounts of chemical research · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 6 countries.

Joana RoloLaboratory of Molecular Genetics, Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa (ITQB-NOVA), Oeiras, Portugal.ORCID 0000-0002-5291-212X
Peder WorningMRSA Knowledge Center, Department of Clinical Microbiology, Hvidovre Hospital, Hvidovre, Denmark.
Jesper Boye NielsenMRSA Knowledge Center, Department of Clinical Microbiology, Hvidovre Hospital, Hvidovre, Denmark.
Rita SobralUCIBIO-REQUIMTE, Departamento de Ciências da Vida, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, Caparica, Portugal.ORCID 0000-0003-4533-7531
Rory BowdenDepartment of Statistics, University of Oxford, Oxford, United Kingdom.
Ons BouchamiLaboratory of Molecular Genetics, Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa (ITQB-NOVA), Oeiras, Portugal.
Peter DamborgDepartment of Veterinary Disease Biology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Luca GuardabassiDepartment of Veterinary Disease Biology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Vincent PerretenDepartment of Molecular Epidemiology and Infectious Diseases, Institute of Veterinary Bacteriology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.ORCID 0000-0001-5722-9445
Henrik WesthMRSA Knowledge Center, Department of Clinical Microbiology, Hvidovre Hospital, Hvidovre, Denmark.
Alexander TomaszLaboratory of Microbiology and Infectious Diseases, The Rockefeller University, New York, United States of America.
Hermínia de LencastreLaboratory of Molecular Genetics, Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa (ITQB-NOVA), Oeiras, Portugal.
Maria MiragaiaLaboratory of Molecular Genetics, Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa (ITQB-NOVA), Oeiras, Portugal.ORCID 0000-0002-1323-7184
Universidade Nova de Lisboa · PTUniversity of Copenhagen · DKHvidovre Hospital · DKRockefeller University · USRede de Química e Tecnologia · PTUniversity of Bern · CHUniversity of Oxford · GB

Funding

S.AUREUS CELL WALLS AND DRUG RESISTANCE IN MRSA AND VRSAR01AI045738 · NIAID · ROCKEFELLER UNIVERSITY · PI TOMASZ, ALEXANDER · 2000 to 2014
$8.5M
NIAID NIH HHS R01 AI045738
6 · The paper itself

Abstract

The epidemiologically most important mechanism of antibiotic resistance in Staphylococcus aureus is associated with mecA-an acquired gene encoding an extra penicillin-binding protein (PBP2a) with low affinity to virtually all β-lactams. The introduction of mecA into the S. aureus chromosome has led to the emergence of methicillin-resistant S. aureus (MRSA) pandemics, responsible for high rates of mortality worldwide. Nonetheless, little is known regarding the origin and evolution of mecA. Different mecA homologues have been identified in species belonging to the Staphylococcus sciuri group representing the most primitive staphylococci. In this study we aimed to identify evolutionary steps linking these mecA precursors to the β-lactam resistance gene mecA and the resistance phenotype. We sequenced genomes of 106 S. sciuri, S. vitulinus and S. fleurettii strains and determined their oxacillin susceptibility profiles. Single-nucleotide polymorphism (SNP) analysis of the core genome was performed to assess the genetic relatedness of the isolates. Phylogenetic analysis of the mecA gene homologues and promoters was achieved through nucleotide/amino acid sequence alignments and mutation rates were estimated using a Bayesian analysis. Furthermore, the predicted structure of mecA homologue-encoded PBPs of oxacillin-susceptible and -resistant strains were compared. We showed for the first time that oxacillin resistance in the S. sciuri group has emerged multiple times and by a variety of different mechanisms. Development of resistance occurred through several steps including structural diversification of the non-binding domain of native PBPs; changes in the promoters of mecA homologues; acquisition of SCCmec and adaptation of the bacterial genetic background. Moreover, our results suggest that it was exposure to β-lactams in human-created environments that has driven evolution of native PBPs towards a resistance determinant. The evolution of β-lactam resistance in staphylococci highlights the numerous resources available to bacteria to adapt to the selective pressure of antibiotics.

Indexed as

Anti-Bacterial AgentsBacterial ProteinsBayes Theorembeta-Lactam Resistancebeta-LactamsHumansMethicillin-Resistant Staphylococcus aureusPenicillin-Binding ProteinsPhylogenyPolymorphism, Single NucleotideStaphylococcal InfectionsStaphylococcusAnti-Bacterial AgentsBacterial Proteinsbeta-LactamsmecA protein, Staphylococcus aureusPenicillin-Binding Proteins

Identifiers

PMID28394942
PMCPMC5402963
OpenAlexW2605947408

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.